Trial intelligence / Profile preview

Mitomycin C versus triamcinolone injections for hypertrophic burn scars

IRCT20230212057391N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of mitomycin c in Hypertrophic Scar (HS) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Feb 2023; status: completed.

02

Drugs

mitomycin c
03

Conditions

Hypertrophic Scar (HS)

Beyond the preview

Go deeper on IRCT20230212057391N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230212057391N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call